Register Login

ADC THERAPEUTICS SA (ADCT)

SymbolADCT
NameADC THERAPEUTICS SA
SectorHEALTH CARE
RegionEurope
IndustryBiotechnology: Pharmaceutical Preparations
AddressBIOPLE,ROUTE DE LA CORNICHE 3B, EPALINGES, 1066, Switzerland
Telephone+41 21 - 653 02 00
Fax—
Email—
Websitehttps://www.adctherapeutics.com
IncorporationUNDEFINED
Incorporated On—
Employees—
Fiscal Year—
Public Since—
ExchangesNASDAQ
Auditor—
Audit StatusNOT PROVIDED
Reporting Status—
CIK0001771910
Description

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The companys product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.

Additional info from NASDAQ:
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The companys product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.

2026-09-03 11:15

ADC Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference

Read more
2026-08-14 17:39

New Form SCHEDULE 13G - ADC Therapeutics SA <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001104659-26-097255 <b>Size:</b> 10 KB

Read more
2026-08-13 17:45

New Form S-8 - ADC Therapeutics SA <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0000950103-26-012337 <b>Size:</b> 215 KB

Read more
2026-08-13 11:30

ADC Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Updates

Read more
2026-08-06 11:30

ADC Therapeutics to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026

Read more
2026-07-27 17:26

New Form SCHEDULE 13G - ADC Therapeutics SA <b>Filed:</b> 2026-07-27 <b>AccNo:</b> 0002012383-26-002147 <b>Size:</b> 10 KB

Read more
2026-07-02 21:17

Zaki Mohamed 🟢 acquired 213.9K shares of ADC Therapeutics SA (ADCT) Transaction Date: Jun 30, 2026 | Filing ID: 047036

Read more
2026-07-02 21:16

GRAHAM PETER J 🟢 acquired 221.1K shares of ADC Therapeutics SA (ADCT) Transaction Date: Jun 30, 2026 | Filing ID: 047034

Read more
2026-07-02 21:16

Carmona Jose 🟢 acquired 203.7K shares of ADC Therapeutics SA (ADCT) Transaction Date: Jun 30, 2026 | Filing ID: 047033

Read more
2026-07-02 21:15

Director MALLIK AMEET 🟢 acquired 675.0K shares of ADC Therapeutics SA (ADCT) Transaction Date: Jun 30, 2026 | Filing ID: 047031

Read more